Cantai Therapeutics
About:
Cantai Therapeutics operates as a developer of drug candidates.
Top Investors: Agent Capital, Tellus BioVentures, 82VS
Description:
Cantai Therapeutics operates as a developer of drug candidates.
Total Funding Amount:
$700000
Headquarters Location:
Philadelphia, Pennsylvania, United States
Founded Date:
2023-01-01
Founders:
Number of Employees:
Last Funding Date:
2023-11-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai